• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄与甲状腺髓样癌特异性死亡率的关系。

Association between age and disease specific mortality in medullary thyroid cancer.

机构信息

Department of Surgery, The University of Virginia Health System, P.O. Box 800681, Charlottesville, VA, 22908, USA.

Endocrine Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 606, Baltimore, MD, 21287, USA.

出版信息

Am J Surg. 2021 Feb;221(2):478-484. doi: 10.1016/j.amjsurg.2020.09.025. Epub 2020 Sep 26.

DOI:10.1016/j.amjsurg.2020.09.025
PMID:33010878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9169693/
Abstract

BACKGROUND

The aim of this study was to evaluate the association between age and disease specific mortality (DSM) among adults diagnosed with medullary thyroid cancer (MTC).

METHOD

Surveillance, Epidemiology, and End Results (SEER-18) was used to analyze adult MTC patients stratified by age (18-64, 65-79, ≥80 years). Associations between patient demographics, tumor size, nodal status, metastatic disease, and extent of surgery on DSM was assessed with multivariable Cox regression.

RESULTS

Among 1457 patients with MTC, 1008 (69.2%) were younger adults, 371 (25.5%) older adults, and 78 (5.4%) were super-elderly. A significantly higher proportion of older adults and super-elderly had less than the recommended operation for MTC. On multivariable analysis, older adults and super-elderly were 2.9 and 6.7 times more likely to have an increased DSM (HR:2.91, 95% CI: 1.83-4.63; p < 0.001 and HR: 6.70, 95%CI: 3.69-12.20; p < 0.001). Extent of surgery or lymphadenectomy did not affect DSM.

CONCLUSIONS

Increased age is an independent predictor of DSM in patients with MTC.

摘要

背景

本研究旨在评估成年人甲状腺髓样癌(MTC)诊断后年龄与疾病特异性死亡率(DSM)之间的关联。

方法

使用监测、流行病学和最终结果(SEER-18)数据库,对年龄(18-64 岁、65-79 岁、≥80 岁)分层的成人 MTC 患者进行分析。使用多变量 Cox 回归评估患者人口统计学特征、肿瘤大小、淋巴结状态、转移性疾病以及手术范围与 DSM 之间的关联。

结果

在 1457 例 MTC 患者中,1008 例(69.2%)为年轻成年人,371 例(25.5%)为老年成年人,78 例(5.4%)为超高龄成年人。更多的老年成年人和超高龄成年人接受的手术不符合 MTC 推荐手术。多变量分析显示,老年成年人和超高龄成年人发生 DSM 增加的风险分别是年轻成年人的 2.9 倍和 6.7 倍(HR:2.91,95%CI:1.83-4.63;p<0.001 和 HR:6.70,95%CI:3.69-12.20;p<0.001)。手术范围或淋巴结清扫术并不影响 DSM。

结论

年龄增长是 MTC 患者 DSM 的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/e09ff28f9e73/nihms-1806586-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/76c1f46a3498/nihms-1806586-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/84d38572f439/nihms-1806586-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/944ea84f8198/nihms-1806586-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/e09ff28f9e73/nihms-1806586-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/76c1f46a3498/nihms-1806586-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/84d38572f439/nihms-1806586-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/944ea84f8198/nihms-1806586-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8e7/9169693/e09ff28f9e73/nihms-1806586-f0004.jpg

相似文献

1
Association between age and disease specific mortality in medullary thyroid cancer.年龄与甲状腺髓样癌特异性死亡率的关系。
Am J Surg. 2021 Feb;221(2):478-484. doi: 10.1016/j.amjsurg.2020.09.025. Epub 2020 Sep 26.
2
Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.与甲状腺髓样癌患者再次手术和疾病特异性死亡率相关的危险因素。
JAMA Surg. 2018 Jan 1;153(1):52-59. doi: 10.1001/jamasurg.2017.3555.
3
Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.社会经济地位和种族/民族与甲状腺髓样癌患者治疗和生存的关系。
JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):763-71. doi: 10.1001/jamaoto.2016.1051.
4
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
5
Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.甲状腺髓样癌手术后的长期预后:单中心经验
World J Surg. 2018 Feb;42(2):367-375. doi: 10.1007/s00268-017-4321-z.
6
Survival Outcome and Optimal Candidates of Primary Tumor Resection for Patients With Metastatic Medullary Thyroid Cancer.转移性甲状腺髓样癌患者行原发灶切除术的生存结局和最佳候选人群。
J Clin Endocrinol Metab. 2024 Oct 15;109(11):2979-2985. doi: 10.1210/clinem/dgae214.
7
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.过去30年甲状腺髓样癌患者的临床表现、治疗及生存趋势。
Surgery. 2017 Jan;161(1):137-146. doi: 10.1016/j.surg.2016.04.053. Epub 2016 Nov 11.
8
Treatment Variation in Older Adults With Differentiated Thyroid Cancer.分化型甲状腺癌老年患者的治疗差异
J Surg Res. 2020 Oct;254:154-164. doi: 10.1016/j.jss.2020.04.013. Epub 2020 May 21.
9
Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study.对于 T1 期甲状腺髓样癌,不进行淋巴结清扫的甲状腺切除术应被视为一种选择:一项基于人群的队列研究。
Front Endocrinol (Lausanne). 2024 Aug 29;15:1433329. doi: 10.3389/fendo.2024.1433329. eCollection 2024.
10
Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.细针穿刺细胞学检查中识别甲状腺髓样癌的障碍:对新的美国甲状腺协会指南有意义的启示。
Cancer Cytopathol. 2018 Jun;126(6):397-405. doi: 10.1002/cncy.21990. Epub 2018 Mar 26.

引用本文的文献

1
The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists.甲状腺髓样癌的诊断挑战:细胞病理学家实用指南。
Cancer Cytopathol. 2025 Jun;133(6):e70023. doi: 10.1002/cncy.70023.
2
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment.老年人群癌症流行病学:实体恶性肿瘤治疗中年龄相关差异的系统评价
Curr Oncol Rep. 2025 Mar;27(3):290-311. doi: 10.1007/s11912-025-01638-6. Epub 2025 Feb 15.
3
Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: a SEER program-based study.间变性甲状腺癌患者生存列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)计划的研究
Discov Oncol. 2024 Nov 13;15(1):650. doi: 10.1007/s12672-024-01537-5.
4
Distinct Impacts of Clinicopathological and Mutational Profiles on Long-Term Survival and Recurrence in Medullary Thyroid Carcinoma.临床病理特征和突变谱对甲状腺髓样癌长期生存及复发的不同影响
Endocrinol Metab (Seoul). 2024 Dec;39(6):877-890. doi: 10.3803/EnM.2024.2027. Epub 2024 Nov 5.
5
Holomics and Artificial Intelligence-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive Disease.全基因组学与人工智能驱动的甲状腺髓样癌精准肿瘤学:应对一种罕见侵袭性疾病的挑战
Cancers (Basel). 2024 Oct 13;16(20):3469. doi: 10.3390/cancers16203469.
6
Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study.对于 T1 期甲状腺髓样癌,不进行淋巴结清扫的甲状腺切除术应被视为一种选择:一项基于人群的队列研究。
Front Endocrinol (Lausanne). 2024 Aug 29;15:1433329. doi: 10.3389/fendo.2024.1433329. eCollection 2024.
7
Medullary Thyroid Carcinoma in Patients with Graves' Disease-A Case Series and Literature Review.格雷夫斯病患者的甲状腺髓样癌——病例系列及文献综述
J Clin Med. 2024 Jul 27;13(15):4391. doi: 10.3390/jcm13154391.
8
Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching.原发肿瘤切除术后远处转移髓样甲状腺癌的生存改善:基于人群的倾向评分匹配队列研究。
Sci Rep. 2024 Jul 27;14(1):17260. doi: 10.1038/s41598-024-68458-9.
9
Well-defined survival outcome disparity across age cutoffs at 45 and 60 for medullary thyroid carcinoma: a long-term retrospective cohort study of 3601 patients.45 岁和 60 岁年龄界限明确的生存结果差异横跨甲状腺髓样癌:3601 例患者的长期回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Jun 14;15:1393904. doi: 10.3389/fendo.2024.1393904. eCollection 2024.
10
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades.小儿髓样甲状腺癌:60 余年来 144 例患者的临床表现和长期结局。
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2256-2268. doi: 10.1210/clinem/dgae133.

本文引用的文献

1
Treatment Variation in Older Adults With Differentiated Thyroid Cancer.分化型甲状腺癌老年患者的治疗差异
J Surg Res. 2020 Oct;254:154-164. doi: 10.1016/j.jss.2020.04.013. Epub 2020 May 21.
2
Different outcomes in sporadic versus familial medullary thyroid cancer.散发性与家族性甲状腺髓样癌的不同结局。
Head Neck. 2019 Jan;41(1):154-161. doi: 10.1002/hed.25463. Epub 2018 Dec 11.
3
Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer.年龄对分化型甲状腺癌死亡率影响的差异。
Ann Surg Oncol. 2018 Oct;25(11):3193-3199. doi: 10.1245/s10434-018-6668-2. Epub 2018 Jul 23.
4
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.过去30年甲状腺髓样癌患者的临床表现、治疗及生存趋势。
Surgery. 2017 Jan;161(1):137-146. doi: 10.1016/j.surg.2016.04.053. Epub 2016 Nov 11.
5
Prognostic significance and optimal cutoff of age in medullary thyroid cancer.甲状腺髓样癌中年龄的预后意义及最佳临界值
Oncotarget. 2016 Mar 29;7(13):15937-47. doi: 10.18632/oncotarget.7556.
6
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?分化型甲状腺癌的生存:年龄与之有何关系?
Thyroid. 2015 Oct;25(10):1106-14. doi: 10.1089/thy.2015.0104. Epub 2015 Aug 12.
7
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
8
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.预测甲状腺髓样癌患者癌症特异性死亡率的术后列线图
Ann Surg Oncol. 2015 Aug;22(8):2700-6. doi: 10.1245/s10434-014-4208-2. Epub 2014 Nov 4.
9
The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.手术范围和淋巴结转移数量对甲状腺髓样癌患者总生存的影响。
J Clin Endocrinol Metab. 2014 Feb;99(2):448-54. doi: 10.1210/jc.2013-2942. Epub 2013 Nov 25.
10
A population-based prospective cohort study of complications after thyroidectomy in the elderly.基于人群的老年甲状腺切除术术后并发症的前瞻性队列研究。
J Clin Endocrinol Metab. 2012 May;97(5):1645-53. doi: 10.1210/jc.2011-1162. Epub 2012 Mar 14.